Krystal Biotech, Inc.
KRYS • NASDAQ
Krystal Biotech, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Krish S. Krishnan, with a market cap of $7.2B.
CEOKrish S. Krishnan
Next Earnings
Upcoming earnings announcement for Krystal Biotech, Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.49
Revenue Estimate
$112.7M
Earnings History
Past 12 earnings reports for Krystal Biotech, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q4 2025 | $1.70Est: $1.61 | +5.6% | $107.1MEst: $106.5M | +0.5% |  10-K |
| Nov 3, 2025 | Q3 2025 | $2.66Est: $1.12 | +137.5% | $97.8MEst: $92.7M | +5.6% | 10-Q |
| Aug 4, 2025 | Q2 2025 | $1.29Est: $1.29 | 0.0% | $96.0MEst: $91.4M | +5.1% | 10-Q |
| May 6, 2025 | Q1 2025 | $1.20Est: $1.52 | -21.1% | $88.2MEst: $96.2M | -8.3% | 10-Q |
| Feb 19, 2025 | Q4 2024 | $1.52Est: $1.29 | +17.8% | $91.1MEst: $97.0M | -6.0% | 10-K |
| Nov 4, 2024 | Q3 2024 | $0.91Est: $0.90 | +1.1% | $83.8MEst: $82.9M | +1.1% | 10-Q |
| Aug 5, 2024 | Q2 2024 | $0.94Est: $0.62 | +51.6% | $70.3MEst: $64.4M | +9.1% | 10-Q |
| May 6, 2024 | Q1 2024 | $0.46Est: $0.15 | +206.7% | $45.3MEst: $47.4M | -4.6% | 10-Q |
| Feb 26, 2024 | Q4 2023 | $0.30Est: -$0.37 | +181.1% | $42.1MEst: $28.6M | +47.3% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.67Est: -$0.15 | -346.7% | $8.6MEst: $6.4M | +34.3% | — |
| Aug 7, 2023 | Q2 2023 | -$1.25Est: -$0.74 | -68.9% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$1.76Est: -$1.43 | -23.1% | - | — | — |